{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:21:52Z","timestamp":1789924912659,"version":"4.0.1"},"reference-count":70,"publisher":"Akademiai Kiado Zrt.","issue":"25","content-domain":{"domain":["www.akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2025,6,22]]},"abstract":"<jats:p>\n                    <jats:italic>Bevezet\u00e9s:<\/jats:italic>\n                    Az Eur\u00f3pai Kardiol\u00f3gus T\u00e1rsas\u00e1g 2023-ban publik\u00e1lt,\n                    Cardiomyopathia Ir\u00e1nyelve a cardiomyopathi\u00e1k diagnosztik\u00e1j\u00e1ban a\n                    multiparametrikus megk\u00f6zel\u00edt\u00e9s fontoss\u00e1g\u00e1t hangs\u00falyozza. A hypertrophi\u00e1s\n                    cardiomyopathia kivizsg\u00e1l\u00e1s\u00e1ban az echokardiogr\u00e1fia, a sz\u00edv\n                    m\u00e1gnesesrezonancia-vizsg\u00e1lata mellett az EKG is fontos szerepet j\u00e1tszik.\n                    Szakirodalmi adatok alapj\u00e1n a hypertrophi\u00e1s cardiomyopathi\u00e1ban szenved\u0151 betegek\n                    mind\u00f6ssze 4\u201318%-a rendelkezik elt\u00e9r\u00e9s n\u00e9lk\u00fcli EKG-val, \u00e1m a megfigyelt\n                    EKG-elt\u00e9r\u00e9sek gyakorta aspecifikusak.\n                    <jats:italic>C\u00e9lkit\u0171z\u00e9s:<\/jats:italic>\n                    Tercier\n                    kardiol\u00f3giai centrumunk, a Gottsegen Gy\u00f6rgy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet\n                    Sz\u00edvel\u00e9gtelens\u00e9g Ambulanci\u00e1j\u00e1n gondozott, hypertrophi\u00e1s cardiomyopathi\u00e1ban\n                    szenved\u0151 betegpopul\u00e1ci\u00f3 EKG-jellemz\u0151inek \u00e9rt\u00e9kel\u00e9se.\n                    <jats:italic>M\u00f3dszer:<\/jats:italic>\n                    Int\u00e9zet\u00fcnk Sz\u00edvel\u00e9gtelens\u00e9g Ambulanci\u00e1j\u00e1n 2023. 11. 01. \u00e9s 2024. 09. 30. k\u00f6z\u00f6tt\n                    gondoz\u00e1sba vett, a sz\u00edv m\u00e1gnesesrezonancia-vizsg\u00e1lat\u00e1val \u00e9s\/vagy genetikai\n                    vizsg\u00e1lattal igazolt hypertrophi\u00e1s cardiomyopathi\u00e1ban szenved\u0151 betegek adatait,\n                    els\u0151 ambul\u00e1ns EKG-param\u00e9tereit elemezt\u00fck retrospekt\u00edv m\u00f3don.\n                    <jats:italic>Eredm\u00e9nyek:<\/jats:italic>\n                    A vizsg\u00e1lt betegek (n = 72 f\u0151) 58%-a volt\n                    f\u00e9rfi, medi\u00e1n\u00e9letkoruk 49 (34\u201362) \u00e9v, bal kamrai ejekci\u00f3s frakci\u00f3juk 63\n                    (47\u201372)%, NYHA funkcion\u00e1lis oszt\u00e1lyuk 2 (1\u20132) volt, ICD-t\/CRT-D-t 47%-uk viselt.\n                    A balkamraki\u00e1raml\u00e1si-p\u00e1lyaobstrukci\u00f3j\u00e1nak \u226530 Hgmm \u00e9rt\u00e9ke alapj\u00e1n a betegek\n                    31%-a tartozott a hypertrophi\u00e1s obstrukt\u00edv cardiomyopathia csoportba. Az\n                    elemzett EKG-kon a betegek 6%-a pitvarfibrill\u00e1lt, az interatrialis vezet\u00e9si\n                    zavarok a 29%-ukat \u00e9rintett\u00e9k. Atrioventricularis \u00e9s intraventricularis vezet\u00e9si\n                    zavarok a betegek 50%-\u00e1ban jelentkeztek (AV blokk: 20% [PQ-szakasz-megny\u00fal\u00e1s:\n                    18%, II. fok\u00fa AV blokk: 2%, III. fok\u00fa AV blokk: 0%], jobb-Tawara-sz\u00e1rblokk: 14%,\n                    bal-Tawara-sz\u00e1r-blokk: 16%, bal anterior hemiblokk: 13%, bal posterior\n                    hemiblokk: 3%, aspecifikus intraventricularis vezet\u00e9si zavar: 8%). A Cornell, a\n                    Sokolow\u2013Lyon-, illetve a Peguero\u2013Lo Presti \u201ehigh voltage\u201d krit\u00e9riumok\n                    szenzitivit\u00e1sa alacsonynak bizonyult (23\u201314\u201325%). Patol\u00f3gi\u00e1s Q-hull\u00e1m 42%-ban,\n                    QRS-fragment\u00e1ci\u00f3 43%-ban, korrig\u00e1lt QT-id\u0151-megny\u00fal\u00e1s 44%-ban fordult el\u0151.\n                    Repolariz\u00e1ci\u00f3s elt\u00e9r\u00e9sek, mint a T-hull\u00e1m-inverzi\u00f3, a csoport 94%-\u00e1ban,\n                    szignifik\u00e1ns ST-elev\u00e1ci\u00f3 a 21%-\u00e1ban \u00e9s ST-depresszi\u00f3 a 48%-\u00e1ban volt\n                    megfigyelhet\u0151, mind\u00f6ssze a p\u00e1ciensek 3%-a rendelkezett negat\u00edv EKG-val. A\n                    hypertrophi\u00e1s obstrukt\u00edv cardiomyopathia \u00e9s a nonobstrukt\u00edv hypertrophi\u00e1s\n                    cardiomyopathia alcsoportok k\u00f6z\u00f6tt egyed\u00fcl a Cornell-krit\u00e9rium gyakoris\u00e1g\u00e1ban\n                    ad\u00f3dott k\u00fcl\u00f6nbs\u00e9g (45% vs. 15%, p = 0,044).\n                    <jats:italic>K\u00f6vetkeztet\u00e9s:<\/jats:italic>\n                    A\n                    hypertrophi\u00e1s cardiomyopathia diagnosztik\u00e1j\u00e1ban elengedhetetlen a multimod\u00e1lis\n                    szeml\u00e9let. Eredm\u00e9nyeink alapj\u00e1n hypertrophi\u00e1s cardiomyopathi\u00e1ban gyakorta\n                    azonos\u00edthat\u00f3k heterog\u00e9n EKG-elt\u00e9r\u00e9sek, \u00e1m a gyan\u00fajelek id\u0151beli felismer\u00e9se a\n                    tov\u00e1bbi diagnosztikus l\u00e9p\u00e9seket seg\u00edtheti, hozz\u00e1j\u00e1rulva a c\u00e9lzott kezel\u00e9s\n                    megkezd\u00e9s\u00e9hez, a progn\u00f3zis jav\u00edt\u00e1s\u00e1hoz. Orv Hetil. 2025; 166(25): 970\u2013981.\n                  <\/jats:p>","DOI":"10.1556\/650.2025.33289","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T05:33:38Z","timestamp":1750570418000},"page":"970-981","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":2,"title":["EKG-elt\u00e9r\u00e9sek gyakoris\u00e1ga hypertrophi\u00e1s cardiomyopathi\u00e1ban: aki keres, az tal\u00e1l"],"prefix":"10.1556","volume":"166","author":[{"given":"Zsolt","family":"Forrai","sequence":"first","affiliation":[{"name":"Gottsegen Gy\u00f6gy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet, Feln\u0151tt Kardiol\u00f3giai Oszt\u00e1ly Budapest, Haller u. 29., 1096 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanni","family":"B\u00e1nfi-Bacs\u00e1rdi","sequence":"additional","affiliation":[{"name":"Gottsegen Gy\u00f6gy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet, Feln\u0151tt Kardiol\u00f3giai Oszt\u00e1ly Budapest, Haller u. 29., 1096 Magyarorsz\u00e1g"},{"name":"Szegedi Tudom\u00e1nyegyetem, Szent-Gy\u00f6rgyi Albert Orvostudom\u00e1nyi Kar, Klinikai Orvostudom\u00e1nyi Doktori Iskola Szeged Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1vid","family":"Pilecky","sequence":"additional","affiliation":[{"name":"Gottsegen Gy\u00f6gy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet, Feln\u0151tt Kardiol\u00f3giai Oszt\u00e1ly Budapest, Haller u. 29., 1096 Magyarorsz\u00e1g"},{"name":"Szegedi Tudom\u00e1nyegyetem, Szent-Gy\u00f6rgyi Albert Orvostudom\u00e1nyi Kar, Klinikai Orvostudom\u00e1nyi Doktori Iskola Szeged Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s G.","family":"Gergely","sequence":"additional","affiliation":[{"name":"Gottsegen Gy\u00f6gy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet, Feln\u0151tt Kardiol\u00f3giai Oszt\u00e1ly Budapest, Haller u. 29., 1096 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Fanni","family":"Hanuska","sequence":"additional","affiliation":[{"name":"Gottsegen Gy\u00f6gy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet, Feln\u0151tt Kardiol\u00f3giai Oszt\u00e1ly Budapest, Haller u. 29., 1096 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l P\u00e9ter","family":"Sch\u00e4ffer","sequence":"additional","affiliation":[{"name":"Gottsegen Gy\u00f6gy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet, Feln\u0151tt Kardiol\u00f3giai Oszt\u00e1ly Budapest, Haller u. 29., 1096 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1d\u00e1m","family":"Kazay","sequence":"additional","affiliation":[{"name":"Gottsegen Gy\u00f6gy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet, Feln\u0151tt Kardiol\u00f3giai Oszt\u00e1ly Budapest, Haller u. 29., 1096 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"V\u00e9rtes","sequence":"additional","affiliation":[{"name":"Gottsegen Gy\u00f6gy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet, Feln\u0151tt Kardiol\u00f3giai Oszt\u00e1ly Budapest, Haller u. 29., 1096 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1t\u00e9","family":"V\u00e1mos","sequence":"additional","affiliation":[{"name":"Szegedi Tudom\u00e1nyegyetem, Szent-Gy\u00f6rgyi Albert Orvostudom\u00e1nyi Kar, Klinikai Orvostudom\u00e1nyi Doktori Iskola Szeged Magyarorsz\u00e1g"},{"name":"Szegedi Tudom\u00e1nyegyetem, Szent-Gy\u00f6rgyi Albert Orvostudom\u00e1nyi Kar, Belgy\u00f3gy\u00e1szati Klinika, Kardiol\u00f3giai Centrum, Elektrofiziol\u00f3giai R\u00e9szleg Szeged Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Andr\u00e9ka","sequence":"additional","affiliation":[{"name":"Gottsegen Gy\u00f6gy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet, Feln\u0151tt Kardiol\u00f3giai Oszt\u00e1ly Budapest, Haller u. 29., 1096 Magyarorsz\u00e1g"},{"name":"Semmelweis Egyetem Doktori Iskola, R\u00e1cz K\u00e1roly Konzervat\u00edv Orvostudom\u00e1nyi Tagozat Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Pir\u00f3th","sequence":"additional","affiliation":[{"name":"Gottsegen Gy\u00f6gy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet, Feln\u0151tt Kardiol\u00f3giai Oszt\u00e1ly Budapest, Haller u. 29., 1096 Magyarorsz\u00e1g"},{"name":"Semmelweis Egyetem Doktori Iskola, R\u00e1cz K\u00e1roly Konzervat\u00edv Orvostudom\u00e1nyi Tagozat Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mi","family":"Nyolczas","sequence":"additional","affiliation":[{"name":"Szegedi Tudom\u00e1nyegyetem, Szent-Gy\u00f6rgyi Albert Orvostudom\u00e1nyi Kar, Klinikai Orvostudom\u00e1nyi Doktori Iskola Szeged Magyarorsz\u00e1g"},{"name":"\u00c9szak-Pesti Centrumk\u00f3rh\u00e1z \u2013 Honv\u00e9dk\u00f3rh\u00e1z, Kardiol\u00f3giai Oszt\u00e1ly Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Muk","sequence":"additional","affiliation":[{"name":"Gottsegen Gy\u00f6gy Orsz\u00e1gos Kardiovaszkul\u00e1ris Int\u00e9zet, Feln\u0151tt Kardiol\u00f3giai Oszt\u00e1ly Budapest, Haller u. 29., 1096 Magyarorsz\u00e1g"},{"name":"Szegedi Tudom\u00e1nyegyetem, Szent-Gy\u00f6rgyi Albert Orvostudom\u00e1nyi Kar, Klinikai Orvostudom\u00e1nyi Doktori Iskola Szeged Magyarorsz\u00e1g"},{"name":"Semmelweis Egyetem Doktori Iskola, R\u00e1cz K\u00e1roly Konzervat\u00edv Orvostudom\u00e1nyi Tagozat Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Elliott P, Andersson B, Arbustini E, et al. Classification of the\n                    cardiomyopathies: a position statement from the European Society Of Cardiology\n                    Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008; 29:\n                    270\u2013276.","DOI":"10.1093\/eurheartj\/ehm342"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2023 focused update of the\n                    2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart\n                    failure. Eur Heart J. 2023; 44: 3627\u20133639. Erratum: Eur Heart J. 2024; 45:\n                    53.","DOI":"10.1093\/eurheartj\/ehad613"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC guidelines for\n                    the management of cardiomyopathies. Eur Heart J. 2023; 44:\n                    3503\u20133626.","DOI":"10.1093\/eurheartj\/ehad194"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Braunwald E. Advances in the treatment of hypertrophic\n                    cardiomyopathy. Eur Heart J. 2024; 45: 5084\u20135086.","DOI":"10.1093\/eurheartj\/ehae710"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Muk B, B\u00e1nfi-Bacs\u00e1rdi F, V\u00e1mos M, et al. The impact of specialised\n                    heart failure outpatient care on the long-term application of guideline-directed\n                    medical therapy and on prognosis in heart failure with reduced ejection\n                    fraction. Diagnostics (Basel) 2024; 14: 131.","DOI":"10.3390\/diagnostics14020131"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"V\u00e1mos M, Healey JS, Wang J, et al. Implantable\n                    cardioverter-defibrillator therapy in hypertrophic cardiomyopathy. A SIMPLE\n                    substudy. Heart Rhythm. 2018; 15: 386\u2013392.","DOI":"10.1016\/j.hrthm.2017.11.020"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Sisakian H. Cardiomyopathies: evolution of pathogenesis concepts and\n                    potential for new therapies. World J Cardiol. 2014; 6: 478\u2013494.","DOI":"10.4330\/wjc.v6.i6.478"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet 2013; 381:\n                    242\u2013255.","DOI":"10.1016\/S0140-6736(12)60397-3"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Rapezzi C, Arbustini E, Caforio AL, et al. Diagnostic work-up in\n                    cardiomyopathies: bridging the gap between clinical phenotypes and final\n                    diagnosis. A position statement from the ESC Working Group on Myocardial and\n                    Pericardial Diseases. Eur Heart J. 2013; 34: 1448\u20131458.","DOI":"10.1093\/eurheartj\/ehs397"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Palinkas ED, Re F, Peteiro J, et al. Pulmonary congestion during\n                    exercise stress echocardiography in hypertrophic cardiomyopathy. Int J\n                    Cardiovasc Imaging 2022; 38: 2593\u20132604.","DOI":"10.1007\/s10554-022-02620-0"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"P\u00e1link\u00e1s ED, Sepp R, Olivotto I. A new chapter in the management of\n                    hypertrophic cardiomyopathy: cardiac myosin inhibitors. Cardiol Hung. 2023; 53:\n                    337\u2013342.","DOI":"10.26430\/CHUNGARICA.2023.53.4.337"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"B\u00e1nfi-Bacs\u00e1rdi F, Boldizs\u00e1r EM, Gergely GT, et al. The role of\n                    complex patient education program in heart failure care. [A komplex\n                    betegoktat\u00e1si program szerepe a sz\u00edvel\u00e9gtelens\u00e9gben szenved\u0151 betegek\n                    gondoz\u00e1s\u00e1ban.] Orv Hetil. 2024; 165: 1461\u20131471. [Hungarian]","DOI":"10.1556\/650.2024.33121"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Jaarsma T, Hill L, Bayes-Genis A, et al. Self-care of heart failure\n                    patients: practical management recommendations from the Heart Failure\n                    Association of the European Society of Cardiology. Eur J Heart Fail. 2021; 23:\n                    157\u2013174.","DOI":"10.1002\/ejhf.2008"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Orosz A, Baczk\u00f3 I, Nagy V, et al. Short-term beat-to-beat\n                    variability of the QT interval is increased and correlates with parameters of\n                    left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Can J\n                    Physiol Pharmacol. 2015; 93: 765\u2013772.","DOI":"10.1139\/cjpp-2014-0526"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"B\u00e1nfi-Bacs\u00e1rdi F, Kazay A, Gergely GT, et al. Therapeutic\n                    consequences and prognostic impact of multimorbidity in heart failure: time to\n                    act. J Clin Med. 2025; 14: 139.","DOI":"10.3390\/jcm14010139"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Muk B, Pilecky D, B\u00e1nfi-Bacs\u00e1rdi F, et al. The changes in the\n                    pharmacotherapy of heart failure with reduced ejection fraction and its effect\n                    on prognosis: experience in the Hungarian clinical practice. [A cs\u00f6kkent\n                    ejekci\u00f3s frakci\u00f3j\u00fa sz\u00edvel\u00e9gtelens\u00e9g gy\u00f3gyszeres kezel\u00e9s\u00e9nek v\u00e1ltoz\u00e1sa \u00e9s a\n                    progn\u00f3zisra gyakorolt hat\u00e1sa a hazai gyakorlatban.] Orv Hetil. 2024; 165:\n                    698\u2013710. [Hungarian]","DOI":"10.1556\/650.2024.33045"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Blazs\u00f3 P, K\u00e1konyi K, Forster T, et al. Cardiomyopathy and ion\n                    channel diseases registry: the Szeged CardioGen Registry. [Cardiomyopathi\u00e1s \u00e9s\n                    ioncsatorna-betegek regisztere: a Szegedi CardioGen Regiszter.] Orv Hetil. 2017;\n                    158: 101\u2013105. [Hungarian]","DOI":"10.1556\/650.2017.30659"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Charron P, Elliott PM, Gimeno JR, et al. The Cardiomyopathy Registry\n                    of the EURObservational Research Programme of the European Society of\n                    Cardiology: baseline data and contemporary management of adult patients with\n                    cardiomyopathies. Eur Heart J. 2018; 39: 1784\u20131793.","DOI":"10.1093\/eurheartj\/ehx819"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Sepp R, Hategan L, Cs\u00e1nyi B, et al. The genetic architecture of\n                    hypertrophic cardiomyopathy in Hungary: analysis of 242 patients with a panel of\n                    98 genes. Diagnostics (Basel) 2022; 12: 1132.","DOI":"10.3390\/diagnostics12051132"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Dohy Z, Vereckei A, Horv\u00e1th V, et al. How are ECG parameters related\n                    to cardiac magnetic resonance images? Electrocardiographic predictors of left\n                    ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.\n                    Ann Noninvasive Electrocardiol. 2020; 25: e12763.","DOI":"10.1111\/anec.12763"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Domsik P, Kalapos A, Chadaide S, et al. Three-dimensional speckle\n                    tracking echocardiography allows detailed evaluation of left atrial function in\n                    hypertrophic cardiomyopathy. Insights from the MAGYAR-Path Study.\n                    Echocardiography 2014; 31: 1245\u20131252.","DOI":"10.1111\/echo.12568"},{"key":"R22","unstructured":"Faludi R, T\u00f3th L, Poto L, et al. Correlation of B-type natriuretic\n                    peptide (NT-proBNP) levels and conventional and tissue Doppler echocardiographic\n                    parameters of left ventricular diastolic function in patients with hypertrophic\n                    cardiomyopathy. [A B-t\u00edpus\u00fa natriureticus peptid (NT-proBNP) szint \u00e9s a\n                    diastol\u00e9s funkci\u00f3t jellemz\u0151 hagyom\u00e1nyos \u00e9s sz\u00f6veti Doppler-echokardiogr\u00e1fi\u00e1s\n                    param\u00e9terek kapcsolata hypertrophi\u00e1s cardiomyopathi\u00e1ban szenved\u0151 betegekben.]\n                    Orv Hetil. 2005; 146: 23\u201326. [Hungarian]"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"McLeod CJ, Ackerman MJ, Nishimura RA, et al. Outcome of patients\n                    with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll\n                    Cardiol. 2009; 54: 229\u2013233.","DOI":"10.1016\/j.jacc.2009.02.071"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Biagini E, Pazzi C, Olivotto I, et al. Usefulness of\n                    electrocardiographic patterns at presentation to predict long-term risk of\n                    cardiac death in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2016;\n                    118: 432\u2013439.","DOI":"10.1016\/j.amjcard.2016.05.023"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Cronin H, Vaughan C, Gallagher M, et al. 41\u2005Promise or peril: the\n                    ECG in hypertrophic cardiomyopathy. Heart 2022; 108(Suppl. 3)\n                    A35.","DOI":"10.1136\/heartjnl-2022-ICS.41"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Finocchiaro G, Sheikh N, Biagini E, et al. The electrocardiogram in\n                    the diagnosis and management of patients with hypertrophic cardiomyopathy. Heart\n                    Rhythm. 2020; 17: 142\u2013151.","DOI":"10.1016\/j.hrthm.2019.07.019"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Bazett HC. An analysis of the time-relations of electrocardiograms.\n                    Ann Noninv Electrocardiol. 1997: 2: 177\u2013194.","DOI":"10.1111\/j.1542-474X.1997.tb00325.x"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Tomcs\u00e1nyi J. Interatrial block and its clinical relevance.\n                    Renaissance of an ECG change. [Az interatrialis blokk \u00e9s klinikai jelent\u0151s\u00e9ge.\n                    Egy EKG-entit\u00e1s renesz\u00e1nsza.] Orv Hetil. 2018; 159: 91\u201395.\n                    [Hungarian]","DOI":"10.1556\/650.2018.30947"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Rautaharju PM, Surawicz B, Gettes LS, et al. AHA\/ACCF\/HRS\n                    recommendations for the standardization and interpretation of the\n                    electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval:\n                    a scientific statement from the American Heart Association Electrocardiography\n                    and Arrhythmias Committee, Council on Clinical Cardiology; the American College\n                    of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the\n                    International Society for Computerized Electrocardiology. J Am Coll Cardiol.\n                    2009; 53: 982\u2013991.","DOI":"10.1161\/CIRCULATIONAHA.108.191096"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Strauss DG. Importance of defining left bundle branch block. J\n                    Electrocardiol. 2012; 45: 505\u2013507.","DOI":"10.1016\/j.jelectrocard.2012.06.023"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac\n                    chamber quantification by echocardiography in adults: an update from the\n                    American Society of Echocardiography and the European Association of\n                    Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16: 233\u2013270.\n                    Erratum: Eur Heart J Cardiovasc Imaging. 2016; 17: 412. Erratum: Eur Heart J\n                    Cardiovasc Imaging. 2016; 17: 969.","DOI":"10.1093\/ehjci\/jew041"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Casale PN, Devereux RB, Kligfield P, et al. Electrocardiographic\n                    detection of left ventricular hypertrophy: development and prospective\n                    validation of improved criteria. J Am Coll Cardiol. 1985; 6:\n                    572\u2013580.","DOI":"10.1016\/S0735-1097(85)80115-7"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Sokolow M, Lyon TP. The ventricular complex in left ventricular\n                    hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;\n                    37: 161\u2013186.","DOI":"10.1016\/0002-8703(49)90562-1"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Peguero JG, Lo Presti S, Perez J, et al. Electrocardiographic\n                    criteria for the diagnosis of left ventricular hypertrophy. J Am Coll Cardiol.\n                    2017; 69: 1694\u20131703.","DOI":"10.1016\/j.jacc.2017.01.037"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Romhilt DW, Estes EH Jr. A point-score system for the ECG diagnosis\n                    of left ventricular hypertrophy. Am Heart J. 1968; 75: 752\u2013758.","DOI":"10.1016\/0002-8703(68)90035-5"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Milnor WR. Electrocardiogram and vectorcardiogram in right\n                    ventricular hypertrophy and right bundle-branch block. Circulation 1957; 16:\n                    348\u2013367.","DOI":"10.1161\/01.CIR.16.3.348"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"Surawicz B, Childers R, Deal BJ, et al. AHA\/ACCF\/HRS recommendations\n                    for the standardization and interpretation of the electrocardiogram. Part III.\n                    Intraventricular conduction disturbances: a scientific statement from the\n                    American Heart Association Electrocardiography and Arrhythmias Committee,\n                    Council on Clinical Cardiology; the American College of Cardiology Foundation;\n                    and the Heart Rhythm Society. Endorsed by the International Society for\n                    Computerized Electrocardiology. J Am Coll Cardiol. 2009; 53:\n                    976\u2013981.","DOI":"10.1161\/CIRCULATIONAHA.108.191095"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Hancock EW, Deal BJ, Mirvis DM, et al. AHA\/ACCF\/HRS recommendations\n                    for the standardization and interpretation of the electrocardiogram. Part V.\n                    Electrocardiogram changes associated with cardiac chamber hypertrophy: a\n                    scientific statement from the American Heart Association Electrocardiography and\n                    Arrhythmias Committee, Council on Clinical Cardiology; the American College of\n                    Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the\n                    International Society for Computerized Electrocardiology. J Am Coll Cardiol.\n                    2009; 53: 992\u20131002.","DOI":"10.1161\/CIRCULATIONAHA.108.191097"},{"key":"R39","unstructured":"The Task Force on the management of ST-segment elevation acute\n                    myocardial infarction of the European Society of Cardiology (ESC); Steg PhG,\n                    James SK, Atar D, et al. ESC guidelines for the management of acute myocardial\n                    infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;\n                    33: 2569\u20132619."},{"key":"R40","doi-asserted-by":"crossref","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition\n                    of myocardial infarction. J Am Coll Cardiol. 2018; 72:\n                    2231\u20132264.","DOI":"10.1016\/j.jacc.2018.08.1038"},{"key":"R41","doi-asserted-by":"crossref","unstructured":"Barrab\u00e9s JA, Figueras J, Moure C, et al. Prognostic significance of\n                    ST segment depression in lateral leads I, aVL, V5 and V6 on the admission\n                    electrocardiogram in patients with a first acute myocardial infarction with out\n                    ST segment elevation. J Am Coll Cardiol. 2000; 35: 1813\u20131819.","DOI":"10.1016\/S0735-1097(00)00630-6"},{"key":"R42","unstructured":"Gironi G, Ferrari M, Brugi A. The positive \u201cgiant\u201d T waves in the\n                    precordial leads: their frequency and significance in a study made on 7118\n                    tracings. [Le onde T \u201cgiganti\u201d positive nelle derivazioni precordiali: loro\n                    frequenza e significato in uno studio condotto sopra 7118 tracciati.] Folia\n                    Cardiol. 1966; 25: 215\u2013243. [Italian]"},{"key":"R43","doi-asserted-by":"crossref","unstructured":"Gwag HB, Lee SH, Kim HJ, et al. Low QRS voltage in limb leads\n                    indicates accompanying precordial voltage attenuation resulting in\n                    underestimation of left ventricular hypertrophy. Int J Environ Res Public Health\n                    2021; 18: 12867.","DOI":"10.3390\/ijerph182412867"},{"key":"R44","doi-asserted-by":"crossref","unstructured":"Chinitz JS, Cooper JM, Verdino RJ. Electrocardiogram voltage\n                    discordance: interpretation of low QRS voltage only in the limb leads. J\n                    Electrocardiol. 2008; 41: 281\u2013286.","DOI":"10.1016\/j.jelectrocard.2007.12.001"},{"key":"R45","doi-asserted-by":"crossref","unstructured":"Konno T, Shimizu M, Ino H, et al. Diagnostic value of abnormal Q\n                    waves for identification of preclinical carriers of hypertrophic cardiomyopathy\n                    based on a molecular genetic diagnosis. Eur Heart J. 2004; 25:\n                    246\u2013251.","DOI":"10.1016\/j.ehj.2003.10.031"},{"key":"R46","doi-asserted-by":"crossref","unstructured":"Nemes A, Forster T. Vascular functional alterations in hypertrophic\n                    cardiomyopathy. [A vascularis funkci\u00f3 elt\u00e9r\u00e9sei hypertrophi\u00e1s\n                    cardiomyopathi\u00e1ban.] Orv Hetil. 2013; 154: 1851\u20131857.\n                    [Hungarian]","DOI":"10.1556\/OH.2013.29756"},{"key":"R47","doi-asserted-by":"crossref","unstructured":"Tomcs\u00e1nyi J, Arabadzisz H, Ar\u00e1nyi P, et al. ECG signs mimicking\n                    acute coronary syndrome in septic cardiomyopathies. [Akut coronaria szindr\u00f3m\u00e1t\n                    ut\u00e1nz\u00f3 EKG-jelek szeptikus cardiomyopathi\u00e1kban.] Orv Hetil. 2024; 165:\n                    1871\u20131876. [Hungarian]","DOI":"10.1556\/650.2024.33174"},{"key":"R48","doi-asserted-by":"crossref","unstructured":"Maurizi N, Olivotto I, Maron MS, et al. Lifetime clinical course of\n                    hypertrophic cardiomyopathy: outcome of the historical Florence cohort over 5\n                    decades. JACC Adv. 2023; 2: 100337.","DOI":"10.1016\/j.jacadv.2023.100337"},{"key":"R49","doi-asserted-by":"crossref","unstructured":"Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic\n                    cardiomyopathy in a general population of young adults. Echocardiographic\n                    analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development\n                    in (young) adults. Circulation 1995; 92: 785\u2013789.","DOI":"10.1161\/01.CIR.92.4.785"},{"key":"R50","doi-asserted-by":"crossref","unstructured":"Olivotto I, Cecchi F, Casey SA, et al. Impact of atrial fibrillation\n                    on the clinical course of hypertrophic cardiomyopathy. Circulation 2001; 104:\n                    2517\u20132524.","DOI":"10.1161\/hc4601.097997"},{"key":"R51","doi-asserted-by":"crossref","unstructured":"B\u00e1nfi-Bacs\u00e1rdi F, V\u00e1mos M, Majoros Z, et al. The effect of kidney\n                    function on the optimization of medical therapy and on mortality in heart\n                    failure with reduced ejection fraction. [A vesefunkci\u00f3 hat\u00e1sa a gy\u00f3gyszeres\n                    ter\u00e1pia optimaliz\u00e1l\u00e1s\u00e1ra \u00e9s a mortalit\u00e1sra cs\u00f6kkent ejekci\u00f3s frakci\u00f3j\u00fa\n                    sz\u00edvel\u00e9gtelens\u00e9gben.] Orv Hetil. 2023; 164: 1387\u20131396.\n                    [Hungarian]","DOI":"10.1556\/650.2023.32836"},{"key":"R52","doi-asserted-by":"crossref","unstructured":"Bernardini A, Crotti L, Olivotto I, et al. Diagnostic and prognostic\n                    electrocardiographic features in patients with hypertrophic cardiomyopathy. Eur\n                    Heart J Suppl. 2023; 25(Suppl. C): C173\u2013C178. Erratum: Eur Heart J Suppl. 2023;\n                    25(Suppl. C): suad121. Erratum: Eur Heart J Suppl. 2023; 25(Suppl. C):\n                    C178.","DOI":"10.1093\/eurheartjsupp\/suad074"},{"key":"R53","unstructured":"Maurizi N, Monda E, Biagini E, et al. Hypertrophic cardiomyopathy:\n                    prevalence of disease-specific red flags. Eur Heart J. 2025 Feb 10.\n                    ehaf026."},{"key":"R54","doi-asserted-by":"crossref","unstructured":"Maurizi N, Michels M, Rowin EJ, et al. Clinical course and\n                    significance of hypertrophic cardiomyopathy without left ventricular\n                    hypertrophy. Circulation 2019; 139: 830\u2013833.","DOI":"10.1161\/CIRCULATIONAHA.118.037264"},{"key":"R55","doi-asserted-by":"crossref","unstructured":"Aimo A, Milandri A, Barison A, et al. Electrocardiographic\n                    abnormalities in patients with cardiomyopathies. Heart Fail Rev. 2024; 29:\n                    151\u2013164.","DOI":"10.1007\/s10741-023-10358-7"},{"key":"R56","doi-asserted-by":"crossref","unstructured":"Norrish G, Topriceanu C, Qu C, et al. The role of the\n                    electrocardiographic phenotype in risk stratification for sudden cardiac death\n                    in childhood hypertrophic cardiomyopathy. Eur J Prev Cardiol. 2022; 29:\n                    645\u2013653.","DOI":"10.1093\/eurjpc\/zwab046"},{"key":"R57","doi-asserted-by":"crossref","unstructured":"Taira CA, Opezzo JA, Mayer MA, et al. Cardiovascular drugs inducing\n                    QT prolongation: facts and evidence. Curr Drug Saf. 2010; 5:\n                    65\u201372.","DOI":"10.2174\/157488610789869229"},{"key":"R58","doi-asserted-by":"crossref","unstructured":"Gray B, Ingles J, Medi C, et al. Prolongation of the QTc interval\n                    predicts appropriate implantable cardioverter-defibrillator therapies in\n                    hypertrophic cardiomyopathy. JACC Heart Fail. 2013; 1: 149\u2013155.","DOI":"10.1016\/j.jchf.2013.01.004"},{"key":"R59","doi-asserted-by":"crossref","unstructured":"Koga Y, Yamaga A, Hiyamuta K, et al. Mechanisms of abnormal Q waves\n                    in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography. J\n                    Cardiovasc Electrophysiol. 2004; 15: 1402\u20131408.","DOI":"10.1046\/j.1540-8167.2004.04314.x"},{"key":"R60","doi-asserted-by":"crossref","unstructured":"Pietrasik G, Zar\u0119ba W. QRS fragmentation: diagnostic and prognostic\n                    significance. Cardiol J. 2012; 19: 114\u2013121.","DOI":"10.5603\/CJ.2012.0022"},{"key":"R61","doi-asserted-by":"crossref","unstructured":"Azevedo PM, Guerreiro CE, Ladeiras-Lopes R, et al. P1772. Diagnostic\n                    accuracy of a novel electrocardiographic criterion for the diagnosis of left\n                    ventricular hypertrophy in hypertrophic cardiomyopathy. Eur Heart J. 2019; 40:\n                    ehz748.0524.","DOI":"10.1093\/eurheartj\/ehz748.0524"},{"key":"R62","doi-asserted-by":"crossref","unstructured":"Olivotto I, Maron MS, Autore C, et al. Assessment and significance\n                    of left ventricular mass by cardiovascular magnetic resonance in hypertrophic\n                    cardiomyopathy. J Am Coll Cardiol. 2008; 52: 559\u2013566.","DOI":"10.1016\/j.jacc.2008.04.047"},{"key":"R63","doi-asserted-by":"crossref","unstructured":"Nagy V, P\u00e1link\u00e1s A, T\u00f3th L, et al. Correlation of left ventricular\n                    hypertrophy parameters and MRI derived left ventricular mass in hypertrophic\n                    cardiomyopathy. [Balkamra-hipertr\u00f3fia m\u00e9rt\u00e9k\u00e9t jellemz\u0151 param\u00e9terek \u00f6sszef\u00fcgg\u00e9se\n                    MRI-vel meghat\u00e1rozott bal kamrai izomt\u00f6meggel hipertr\u00f3fi\u00e1s cardiomyopathi\u00e1ban.]\n                    Cardiol Hung. 2020; 50: 17\u201323. [Hungarian]","DOI":"10.26430\/CHUNGARICA.2020.50.1.17"},{"key":"R64","doi-asserted-by":"crossref","unstructured":"Savage DD, Seides SF, Clark CE, et al. Electrocardiographic findings\n                    in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.\n                    Circulation 1978; 58: 402\u2013408.","DOI":"10.1161\/01.CIR.58.3.402"},{"key":"R65","doi-asserted-by":"crossref","unstructured":"de Souza I, Padrao E, Marques IR, et al. Diagnostic accuracy of ECG\n                    to detect left ventricular hypertrophy in patients with left bundle branch\n                    block: a systematic review and meta-analysis. CJC Open 2023; 5:\n                    971\u2013980.","DOI":"10.1016\/j.cjco.2023.08.010"},{"key":"R66","doi-asserted-by":"crossref","unstructured":"DeBauge A, Harvey CJ, Gupta A, et al. Evaluation of\n                    electrocardiographic criteria for predicting left ventricular hypertrophy and\n                    dilation in presence of left bundle branch block. J Electrocardiol. 2024; 87:\n                    153787.","DOI":"10.1016\/j.jelectrocard.2024.153787"},{"key":"R67","doi-asserted-by":"crossref","unstructured":"Guerrier K, Madueme PC, Jefferies JL, et al. Unexpectedly low left\n                    ventricular voltage on ECG in hypertrophic cardiomyopathy. Heart 2016; 102:\n                    292\u2013297.","DOI":"10.1136\/heartjnl-2015-308633"},{"key":"R68","doi-asserted-by":"crossref","unstructured":"Pelliccia A, Drezner JA, Zorzi A, et al. Prevalence and clinical\n                    significance of low QRS voltages in healthy individuals, athletes, and patients\n                    with cardiomyopathy: implications for sports pre-participation cardiovascular\n                    screening. Eur J Prev Cardiol. 2024; 31: 1106\u20131114.","DOI":"10.1093\/eurjpc\/zwae027"},{"key":"R69","doi-asserted-by":"crossref","unstructured":"Martinez-Selles M, Marina-Breysse M. Current and future use of\n                    artificial intelligence in electrocardiography. J Cardiovasc Dev Dis. 2023; 10:\n                    175.","DOI":"10.3390\/jcdd10040175"},{"key":"R70","doi-asserted-by":"crossref","unstructured":"Siontis KC, Wieczorek MA, Maanja M, et al. Hypertrophic\n                    cardiomyopathy detection with artificial intelligence electrocardiography in\n                    international cohorts: an external validation study. Eur Heart J Digit Health\n                    2024; 5: 416\u2013426.","DOI":"10.1093\/ehjdh\/ztae029"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/166\/25\/article-p970.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/166\/25\/article-p970.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/166\/25\/article-p970.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:27:11Z","timestamp":1785421631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/166\/25\/article-p970.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,22]]},"references-count":70,"journal-issue":{"issue":"25"},"URL":"https:\/\/doi.org\/10.1556\/650.2025.33289","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,22]]}}}